| Andrew Thomas, MSN, APN-C | |
|
1 Robert Wood Johnson Pl, New Brunswick, NJ 08901-1928 | |
| (732) 828-3000 | |
| Not Available |
| Full Name | Andrew Thomas |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 1 Robert Wood Johnson Pl, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023003597 | NPI | - | NPPES |
| 01277884 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 26NJ00051700 (New Jersey) | Primary |
| Entity Name | Robert Wood Johnson Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902848625 PECOS PAC ID: 8628065117 Enrollment ID: O20040427001205 |
News Archive
UT Southwestern Medical Center surgeons completed the North Texas region's first robot-assisted bladder removal using the DaVinci system, a four-armed robot controlled by the surgeon via a joystick.
Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.
Following a report that as many as 345 patients may have died from an infection contracted at a British hospital, the chairman of the hospital trust at the centre of the infection scandal has resigned.
Researchers from the University of Texas Medical Branch at Galveston have found, for the first time, that spirometry was underutilized for asthma diagnosis and management in U.S. adults from 2001 to 2011, despite it's accuracy, cost effectiveness and the publication of national guidelines advocating its use.
Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Thomas, MSN, APN-C 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901-1928 Ph: (732) 828-3000 | Andrew Thomas, MSN, APN-C 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901-1928 Ph: (732) 828-3000 |
News Archive
UT Southwestern Medical Center surgeons completed the North Texas region's first robot-assisted bladder removal using the DaVinci system, a four-armed robot controlled by the surgeon via a joystick.
Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.
Following a report that as many as 345 patients may have died from an infection contracted at a British hospital, the chairman of the hospital trust at the centre of the infection scandal has resigned.
Researchers from the University of Texas Medical Branch at Galveston have found, for the first time, that spirometry was underutilized for asthma diagnosis and management in U.S. adults from 2001 to 2011, despite it's accuracy, cost effectiveness and the publication of national guidelines advocating its use.
Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).
› Verified 3 days ago
Mrs. Courtney Elizabeth Resciniti, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 125 Paterson St Ste 3300, New Brunswick, NJ 08901 Phone: 732-235-7821 Fax: 732-235-8878 | |
Lauren Horton, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 200 Somerset St, New Brunswick, NJ 08901 Phone: 888-244-5373 | |
Devon Amanda Orzano, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, 2 Core - Rm. 257, New Brunswick, NJ 08901 Phone: 732-828-3000 | |
Sherene Tanasha Dunkley, APN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-745-8600 | |
Daniela Manole Raabe, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 200 Somerset St, New Brunswick, NJ 08901 Phone: 646-226-2137 | |
Ms. Kathy O Covert, APN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-745-8600 |